HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N,1,4,4- tetramethyl- 8- ((4- (4- methylpiperazin- 1- yl)phenyl)amino)- 4,5- dihydro- 1H- pyrazolo(4,3- h)quinazoline- 3- carboxamide

a cyclin dependent kinase inhibitor
Also Known As:
PHA 848125; PHA-848125; PHA848125
Networked: 5 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ciomei, Marina: 4 articles (09/2012 - 03/2010)
2. Alvino, Ester: 2 articles (09/2012 - 05/2010)
3. D'Atri, Stefania: 2 articles (09/2012 - 05/2010)
4. Caporali, Simona: 2 articles (09/2012 - 05/2010)
5. Levati, Lauretta: 2 articles (09/2012 - 05/2010)
6. Bonmassar, Enzo: 2 articles (09/2012 - 05/2010)
7. Pesenti, Enrico: 2 articles (08/2010 - 03/2010)
8. Alzani, Rachele: 2 articles (08/2010 - 03/2010)
9. Patton, Veronica: 2 articles (08/2010 - 03/2010)
10. Brasca, Maria Gabriella: 2 articles (08/2010 - 05/2010)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Glioma (Gliomas)
3. Neoplasms (Cancer)
4. Leukemia
5. Adenocarcinoma

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Cyclin-Dependent Kinases (cdk Proteins)
3. Growth Factor Receptors
4. Tropomyosin
5. Protein-Tyrosine Kinases (Tyrosine Kinase)
6. Cyclins
7. DNA (Deoxyribonucleic Acid)
8. temozolomide (Temodar)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Oral Administration